---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-211337"
form_type: "8-K"
ticker: "VRCA"
cik: "0001660334"
company_name: "Verrica Pharmaceuticals Inc."
filed_at: "2021-07-09T23:59:59+00:00"
generated_at: "2026-06-30T06:23:27.066179+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Verrica Pharmaceuticals appoints Terry Kohler as CFO, replacing Brian Davis effective July 16, 2021

## Summary
- Brian Davis terminated as CFO effective July 16, 2021; eligible for severance subject to separation agreement.
- Terry Kohler appointed CFO effective July 16, 2021; previously VP of Corporate Development and Treasurer at Endo.
- Kohler receives $350,000 base salary, 40% target bonus, and option to purchase 125,000 shares vesting over 4 years.
- Kohler holds an MBA from UNC Chapel Hill and is a Certified Management Accountant.
- Employment at-will; severance provisions vary based on timing and change in control.

## SEC filing metadata
- accession: 0001193125-21-211337
- form_type: 8-K
- ticker: VRCA
- cik: 0001660334
- company_name: Verrica Pharmaceuticals Inc.
- filed_at: 2021-07-09T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1660334/000119312521211337/0001193125-21-211337-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1660334/000119312521211337/d181869d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-211337
- JSON: https://secwatch.observer/filing/0001193125-21-211337.json
- Plain text: https://secwatch.observer/filing/0001193125-21-211337.txt

## Key facts
- Executive change
  Brian Davis was terminated as Chief Financial Officer at Verrica Pharmaceuticals Inc..
  - Action: terminated
  - Role: Chief Financial Officer
  source text: On July 6, 2021, Verrica Pharmaceuticals Inc. (the “Company”) notified Brian Davis that his employment as Chief Financial Officer of the Company would terminate, effective as of July 16, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1660334/000119312521211337/0001193125-21-211337-index.htm
- Executive change
  Terry Kohler was appointed as Chief Financial Officer at Verrica Pharmaceuticals Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On July 8, 2021 the board of directors (the “Board”) of the Company appointed Terry Kohler as the Company’s Chief Financial Officer, effective as of July 16, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1660334/000119312521211337/0001193125-21-211337-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.